---
layout: splash
title: HLB (028300)
excerpt: HLB의 최근 공시, 수익률, 주요 재무/기술 지표
header:
  overlay_color: "#333"
  show_overlay_excerpt: false
categories:
- KOSDAQ
- Q:제약
- 고PBR
keywords: HLB, 028300
---

| **종가** | **전일대비** | **업종** | **PER** | **PBR** | **DIV** |
| -------: | -----------: | -------: | ------: | ------: | ------: |
| 106,700 | <span style="color: tomato">0.4<small>%</small></span> | Q:제약 | - | 21.2 | - |

<!-- more -->


> **기업 개요**<a id="company"></a>

| <span style="white-space:nowrap;">**섹터**</span> | Q:제약 / 의료용품 및 기타 의약 관련제품 제조업 |
| <span style="white-space:nowrap;">**산업**</span> | 의료기기, 의약외품 등 |
| <span style="white-space:nowrap;">**상장**</span> | KOSDAQ / 1996년 7월 27일 상장 / 12월 결산 |
| <span style="white-space:nowrap;">**대표자**</span> | 진양곤, 백윤기 (각자대표) |
| <span style="white-space:nowrap;">**홈페이지**</span> | [http://hlbbio.co.kr](http://hlbbio.co.kr){:target="_blank"} |


> **최근 7일 DART 신규 공시**<a id="dart"></a>

| **일자** |      | **보고서명** |
| :------- | :--- | :----------- |
| 04&#x2011;22 | | [기업설명회(IR)개최              ](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240422900385){:target="_blank"} |
| 04&#x2011;16 | | [임원ㆍ주요주주특정증권등소유상황보고서](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240416000301){:target="_blank"} |


> **주가 흐름**<a id="price"></a>

![028300](/stock/images/028300.png){: .align-center}


> **주요 가격 변동 지표**<small>[^fn_price_metric]</small>

| **종가** | **전일대비** | **5일** | **20일** | **60일** | **120일** |
| -------: | -----------: | ------: | -------: | -------: | --------: |
| 106,700 | <span style="color: tomato">0.4<small>%</small></span> | <span style="color: tomato">12.2<small>%</small></span> | <span style="color: cornflowerblue">-10.2<small>%</small></span> | <span style="color: tomato">115.6<small>%</small></span> | <span style="color: tomato">264.8<small>%</small></span> |
| **1년** | **편차** | **샤프** | **MDD** | **AvDD** | **MARr** |
| <span style="color: tomato">229.8<small>%</small></span> | 66.1<small>%</small> | 3.48 | -28.7<small>%</small> | -12.9<small>%</small> | -8.0 |


> **주요 재무 지표**<small>[^fn_finance_metric]</small>

| **업종**<small>[^fn_sector_abbr]</small> | **PER** | **PBR** | **DIV** | **평가**<small>[^fn_finance_basic_tags]</small> |
| :--------------------------------------- | ------: | ------: | ------: | ----------------------------------------------: |
| Q:제약 | - | 21.2 | - | 고PBR |



{% include /commons/ads/adsense.html %}

> **세부 재무/투자 정보 제공 사이트**

| [네이버](https://m.stock.naver.com/domestic/stock/028300/finance/summary){:target="_blank"}<sup><small>모바일</small></sup> | [네이버](https://finance.naver.com/item/coinfo.naver?code=028300){:target="_blank"} | [FnGuide](https://comp.fnguide.com/SVO2/ASP/SVD_Invest.asp?gicode=A028300&MenuYn=Y){:target="_blank"} |
| :---: | :---: | :---: |
| [와이즈리포트](https://comp.wisereport.co.kr/company/c1040001.aspx?cmp_cd=028300){:target="_blank"} | [밸류라인](https://www.valueline.co.kr/finance/summary/028300){:target="_blank"} | [한국경제](https://markets.hankyung.com/stock/028300/financial-summary){:target="_blank"} |


> **주요 기술 지표**<small>[^fn_tech_metric]</small>


![028300](/stock/images/028300_tech.png){: .align-center}

| **기술 지표** | **1년** | **편차** | **샤프** | **MDD** | **AvDD** |
| :------------ | ------: | -----------: | -------: | ------: | -------: |
| 거치식 | 229.8<small>%</small> | 66.1<small>%</small> | 3.48 | -28.7<small>%</small> | -12.9<small>%</small> |
| 적립식[^fn_tech_metric_dca] | 176.0<small>%</small> | 65.3<small>%</small> | 2.69 | -30.3<small>%</small> | -10.9<small>%</small> |
| Sig. M[^fn_tech_metric_sigm] | 68.9<small>%</small> | 50.9<small>%</small> | 1.35 | -27.3<small>%</small> | -13.8<small>%</small> |
| SMA<small><sub>(5)</sub></small>[^fn_tech_metric_sma_i] | 34.7<small>%</small> | 48.9<small>%</small> | 0.71 | -39.5<small>%</small> | -19.9<small>%</small> |
| SMA<small><sub>(20)</sub></small>[^fn_tech_metric_sma_i] | 84.3<small>%</small> | 56.2<small>%</small> | 1.50 | -40.0<small>%</small> | -17.1<small>%</small> |
| SMA<small><sub>(60)</sub></small>[^fn_tech_metric_sma_i] | 160.6<small>%</small> | 58.5<small>%</small> | 2.75 | -31.1<small>%</small> | -13.1<small>%</small> |
| SMA<small><sub>(120)</sub></small>[^fn_tech_metric_sma_i] | 194.0<small>%</small> | 59.6<small>%</small> | 3.25 | -28.7<small>%</small> | -13.3<small>%</small> |
| SMA<small><sub>(240)</sub></small>[^fn_tech_metric_sma_i] | 154.2<small>%</small> | 57.4<small>%</small> | 2.69 | -28.7<small>%</small> | -11.8<small>%</small> |
| MACD[^fn_tech_metric_macd] | 81.5<small>%</small> | 50.8<small>%</small> | 1.60 | -17.7<small>%</small> | -9.9<small>%</small> |


> **주가 흐름 유사 종목**<a id="corr"></a><small>[^fn_corr_long]</small>

![028300](/stock/images/028300_corr.png){: .align-center}

|       | [HLB생명과학](/067630/) | [리가켐바이오](/141080/) | [에이비엘바이오](/298380/) |
| :---: | :------------------------------------: | :------------------------------------: | :------------------------------------: |
|       | [녹십자홀딩스](/005250/) | [셀트리온](/068270/) | [삼성물산](/028260/) |


> **가상 레버리지 상품에 투자했다면**<a id="2x"></a><small>[^fn_lev]</small>

![028300](/stock/images/028300_2x.png){: .align-center}


> **관련 정보**

- [Q:제약 업종 목록](/stats/sector/kosdaq_업종_제약_종목/){: .btn .btn--info} [고PBR 목록](/fn/fn_high_pbr/){: .btn .btn--info}

{% include commons/footnotes.md %}